Is a complete NSE/CONCORDBIO research report available?

No complete published report is available for nse/CONCORDBIO (NSE/CONCORDBIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/CONCORDBIO stock profile: metrics, valuation and analysis

Market cap	152B
Revenue (ttm)	11.1B
Net income (ttm)	2.8B
EPS (ttm)	₹26.2
Shares out	104.6M
P/E (trailing)	55.4x
P/E (forward)	41.4x
Dividend	₹7.55 (0.52%)
Volume	106,036
Beta	0.35

All NSE/CONCORDBIO indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

INR

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,624
Employees Change	53%
Employees Change Percent	3.37
Enterprise value	INR 147.7B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Biotechnology
Industry PE	108.2
Industry PE Fwd	49.69
Isin	INE338H01029
Last refreshed	2026-09-11
Market cap	INR 152B
Price	INR 1,445
Price currency	INR
Rev Per Employee	6,825,074.51x
Sector	Healthcare
Sector PE	48.17
Sector PE Fwd	38.6
Sic	2834
Symbol	nse/CONCORDBIO
Website	https://www.concordbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.81%
EV Earnings	53.63x
EV/EBIT	45.07x
EV/EBITDA	36.27x
EV/FCF	85.99x
EV/Sales	13.32x
FCF yield	1.13%
Forward P/E	41.35x
P/B ratio	7.54x
P/E ratio	55.37x
P/S ratio	13.71x
PE Ratio3 Y	51.33x
PEG ratio	2.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.32%
EBITDA Margin	36.32%
FCF margin	16.28%
Gross margin	64.57%
Gross Profit	INR 7.2B
Gross Profit Growth	-7.24%
Gross Profit Growth Q	30.19%
Gross Profit Growth3 Y	2.03%
Net Income	INR 2.8B
Net Income Growth	-22.67%
Net Income Growth Q	32.84%
Net Income Growth Qo Q	-34.09%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	3.93%
Pretax Margin	32.86%
Profit Margin	24.84%
Profit Per Employee	INR 1.7M
Profitable Quarters	INR 17
Profitable Years	7
Roa5y	12.83
Roe5y	18.88
ROIC	15.35
Roic5y	20.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-8.54%
Cagr3y	13.7%
EPS Growth	-22.9
EPS Growth Q	31.12
EPS Growth Qo Q	-34.75
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	3.81
FCF Growth	28.79%
FCF Growth3 Y	19.39%
OCF Growth	9.15%
OCF Growth3 Y	2.75%
Revenue Growth	-6.72x
Revenue Growth Q	26.23x
Revenue Growth Qo Q	-21.03x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	8.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 4.3B
Debt	INR 23.2M
Debt EBITDA	INR 0.01
Debt Equity	INR 0
Debt FCF	INR 0.01
Equity	INR 20.2B
Interest Coverage	1,245
Net Cash	INR 4.3B
Net Cash By Market Cap	INR 2.83
Net Cash Growth	36.47%
Net Debt EBITDA	INR -1.07
Net Debt Equity	INR -0.21
Net Debt FCF	INR -2.5
Tangible Book Value	INR 20.2B
Tangible Book Value Per Share	INR 193
WACC	6.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.29%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	INR 7.55
Dividend Years	3
Dividend Yield	0.52%
Ex Div Date	2026-07-24
Last Dividend	INR 7.55

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-8.54%
200-day SMA	1,266.3
3Y total return	47%
50-day SMA	1,398.7
50-day SMA vs 200-day SMA	50over200
All Time High	2,664
All Time High Change	-45.03%
All Time High Date	2024-09-20
All Time Low	900.1
All Time Low Change	62.71%
All Time Low Date	2023-08-18
ATR	48.58
Beta	0.35
Beta1y	0.12
Beta2y	-0.02
Ch YTD	8.84
High	1,472.2
High52	1,704
High52 Date	2025-09-19
High52ch	-15.19%
Low	1,432
Low52	987
Low52 Date	2026-04-02
Low52ch	46.42%
Ma50ch	4.7%
Price vs 200-day SMA	15.65%
RSI	51.87
RSI Monthly	51.97
RSI Weekly	56.32
Sharpe ratio	-0.26x
Sharpe Ratio3y	0.46x
Sortino ratio	-0.27
Sortino Ratio3y	0.88
Total Return	0.23%
Tr YTD	9.49
Tr1m	7.29%
Tr1w	1.36%
Tr3m	23.11%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,622,351%
Net Borrowing	-6,537,000
Shares Insiders	60.87%
Shares Institutions	16.01%
Shares Out	104,616,204
Shares Qo Q	1.02%
Shares Yo Y	0.29%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	164,274.55x
Bv Per Share	192.8
CAPEX	INR -951.5M
Ch1m	7.29
Ch1w	1.36
Ch1y	-9.08
Ch3m	22.38
Ch3y	44.39
Ch6m	21.31
Change	-1.32%
Change From Open	-1.83
Close	1,464.5
Days Gap	0.53
Depreciation Amortization	775,838,750
Dollar Volume	153,243,221.9
Earnings Date	2026-10-30
EBIT	INR 3.2B
EBITDA	INR 4B
EPS	INR 26.24
F Score	2
FCF	INR 1.7B
FCF EV Yield	1.16x
FCF Per Share	INR 16.42
Financing CF	-1,128,762,000
Fiscal Year End	March
Founded	1,984
Graham Number	337.36578
Graham Upside	-76.66
Income Tax	INR 913.9M
Investing CF	-1,427,236,000
Is Primary Listing	1
Last Earnings Date	2026-07-31
Last Report Date	2026-06-30
Lynch Fair Value	INR 131
Lynch Upside	-90.92
Ma150	1,241.4
Ma150ch	17.97%
Ma20	1,496.6
Ma20ch	-2.15%
Net CF	112,815,000
Next Earnings Date	2026-10-30
Open	1,472.2
P FCF Ratio	88.5
P OCF Ratio	56.95
Payment Date	2026-08-30
Position In Range	32.84
Price Date	2026-09-10
Price EBITDA	INR 37.76
Ptbv Ratio	7.54
Relative Volume	0.65x
Revenue	11,083,921,000x
Tax By Revenue	8.25x
Tax Rate	25.09%
Tr6m	22.04%
Volume	106,036

NSE/CONCORDBIO (NSE/CONCORDBIO)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/CONCORDBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/CONCORDBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/CONCORDBIO

Frequently asked questions